0000904454-21-000539.txt : 20210617
0000904454-21-000539.hdr.sgml : 20210617
20210617110014
ACCESSION NUMBER: 0000904454-21-000539
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210615
FILED AS OF DATE: 20210617
DATE AS OF CHANGE: 20210617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kuta Alexander Edward III
CENTRAL INDEX KEY: 0001696698
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36294
FILM NUMBER: 211023710
MAIL ADDRESS:
STREET 1: 239 WILLIS ROAD
CITY: SUDBURY
STATE: MA
ZIP: 01776
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: uniQure N.V.
CENTRAL INDEX KEY: 0001590560
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: PAASHEUVELWEG 25A
CITY: AMSTERDAM
STATE: P7
ZIP: 1105 BP
BUSINESS PHONE: 1-339-970-7000
MAIL ADDRESS:
STREET 1: PAASHEUVELWEG 25A
CITY: AMSTERDAM
STATE: P7
ZIP: 1105 BP
FORMER COMPANY:
FORMER CONFORMED NAME: uniQure B.V.
DATE OF NAME CHANGE: 20131030
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2021-06-15
0001590560
uniQure N.V.
QURE
0001696698
Kuta Alexander Edward III
C/O UNIQURE N.V.
PAASHEUVELWEG 25A
AMSTERDAM
P7
11058BP
NETHERLANDS
0
1
0
0
Executive VP, Operations
Ordinary Shares
2021-06-15
4
M
0
6000
5.31
A
74871
D
Ordinary Shares
2021-06-15
4
S
0
6000
35.43
D
68871
D
Stock Option (Right to Buy)
5.31
2021-06-15
4
M
0
6000
0
D
2027-01-23
Ordinary Shares
6000
80000
D
The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
The Stock Option vested 25% on January 23, 2018 (the first anniversary of the date of grant), and vests 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates.
/s/ Christian Klemt, Attorney-in-Fact
2021-06-17